Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Loxo Oncology CS (LOXO)

Loxo Oncology CS (LOXO)
234.80 +0.14 (+0.06%) 02/15/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Feb 15th, 2019
Day Low
234.80
Day High
234.80
Open 234.80
Previous Close 234.66 234.66
Volume 800 800
Avg Vol 642,620 642,620
Stochastic %K 84.39% 84.39%
Weighted Alpha +47.60 +47.60
5-Day Change +0.37 (+0.16%) +0.37 (+0.16%)
52-Week Range 103.50 - 234.93 103.50 - 234.93
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,182,943
  • Shares Outstanding, K 30,615
  • Annual Sales, $ 21,300 K
  • Annual Income, $ -148,880 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.51
  • Price/Sales 49.61
  • Price/Cash Flow N/A
  • Price/Book 18.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.09
  • Most Recent Earnings $-0.89 on 11/08/18
  • Next Earnings Date 03/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.16
  • Number of Estimates 8
  • High Estimate -0.56
  • Low Estimate -2.47
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -68.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.14 +0.71%
on 01/16/19
Period Open: 233.67
234.93 -0.06%
on 02/13/19
+1.13 (+0.48%)
since 01/15/19
3-Month
125.00 +87.84%
on 12/24/18
Period Open: 151.53
234.93 -0.06%
on 02/13/19
+83.27 (+54.95%)
since 11/15/18
52-Week
103.50 +126.86%
on 02/20/18
Period Open: 104.97
234.93 -0.06%
on 02/13/19
+129.83 (+123.68%)
since 02/15/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 234.95
1st Resistance Point 234.81
Last Price 234.80
1st Support Level 234.59
2nd Support Level 234.51
3rd Support Level N/A

See More

52-Week High 234.93
Last Price 234.80
Fibonacci 61.8% 184.72
Fibonacci 50% 169.21
Fibonacci 38.2% 153.71
52-Week Low 103.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.